Capricor Inc.
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT05126758) | Capricor Inc. | 2022-06-22 |
| Intravenous Infusion of CAP-1002 in Patients With COVID-19 (NCT04623671) | Capricor Inc. | 2020-11-15 |
| Open-label Extension of the HOPE-2 Trial (NCT04428476) | Capricor Inc. | 2020-08-05 |
| Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) (NCT06304064) | Capricor Inc. | 2018-06-21 |
| A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT03406780) | Capricor Inc. | 2018-04-04 |
Track Capricor Inc. automatically
Every clearance here is in the API, with alerts when new ones post.